The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Toxicities of tyrosine kinase inhibitors: Occurrence of hemoptysis and tracheo-oesophageal fistula in 150 patients with advanced thyroid cancer.
Livia Lamartina
No relevant relationships to disclose
Serena Ippolito
No relevant relationships to disclose
Amandine Berdelou
No relevant relationships to disclose
Abir Al Ghuzlan
No relevant relationships to disclose
Isabelle Borget
No relevant relationships to disclose
Sophie Leboulleux
No relevant relationships to disclose
Dana Hartl
No relevant relationships to disclose
Haitham Mirghani
No relevant relationships to disclose
Pierre Blanchard
No relevant relationships to disclose
Desiree Deandreis
No relevant relationships to disclose
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Eric Baudin
No relevant relationships to disclose